Find participating medical centers and current study status in each of them

    Find participating medical centers

    A study to look at a new medicine called, “GDC-0134”, for treating patients with amyotrophic lateral sclerosis (ALS)

    A Study of GDC-0134 to Determine Initial Safety, Tolerability, and Pharmacokinetic Parameters in Participants With Amyotrophic Lateral Sclerosis

    • Neurodegenerative Disorder
    • Amyotrophic Lateral Sclerosis